MUFG Securities EMEA
ALNY icon

MUFG Securities EMEA’s Alnylam Pharmaceuticals ALNY Stock Holding History

MUFG Securities EMEA’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.09M Buy
8,483
+1,725
+26% +$439K 0.02% 293
2026
Q2 		$2.03M Buy
+6,758
New +$2.04M 0.02% 328
2026
Q1 		– Sell
-15,000
Closed -$5.96M – 553
2025
Q4 		$5.96M Buy
+15,000
New +$6.64M 0.07% 185

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

MUFG Securities EMEA's ALNY Position: Q3 2026 in Review

MUFG Securities EMEA increased its Alnylam Pharmaceuticals (ALNY) stake by 26% in Q3 2026, buying an estimated $439K and bringing the position to 8,483 shares worth $2.09M. The position accounts for 0.02% of the portfolio, ranked #293.

MUFG Securities EMEA first reported a position in ALNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.96M in Q4 2025. 591 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • MUFG Securities EMEA held 8,483 shares of Alnylam Pharmaceuticals worth $2.09M as of Q3 2026.
  • MUFG Securities EMEA bought 1,725 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $439K.
  • Alnylam Pharmaceuticals made up 0.02% of MUFG Securities EMEA's portfolio in Q3 2026, its #293 holding.
  • MUFG Securities EMEA first reported a position in Alnylam Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • MUFG Securities EMEA's Alnylam Pharmaceuticals position peaked at $5.96M in Q4 2025.
  • 591 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on MUFG Securities EMEA's 13F filing for Q3 2026, filed 12 Nov 2026.